Monday, 14th October | 11 a.m. – 7 p.m. PDT
ImaginAb’s Chief Executive Officer, Ian Wilson, will present an update on ImaginaAb and progress achieved with the CD8 ImmunoPET minibody at the upcoming Innovation Showcase 2019 on Monday, October 14, 2019, at The Lundquist Institute (formerly LA BioMed),1124 West Carson Street, Torrance, CA.
The Innovation Showcase is a prestigious forum where academic institutions promote and share their startups and early-stage technologies. ImaginAb joins 24 curated bioscience companies presenting with two tracks – therapeutics and medical device/other – along with a distinguished lineup of speakers that includes Bethany Mancilla, Vice President Corporate Development, Kite Pharma, a Gilead Company; David Meyer, President and Chief Executive Officer, The Lundquist Institute; Frank Stonebanks, Founder, Managing Partner, KickFlip BioVentures; Helen Kim, Managing Director, Vida Ventures.
Thursday, 17th October | 12 p.m. – 5:30 p.m. BST
ImaginAb’s CEO, Ian Wilson, and CBO,Ivan Plavec, will be attending and hosting meetings during the Bloomberg Intelligence and Optimum Strategic Communications Annual Investor Healthcare Conference. Now in its 11th year, the conference brings together the top executives and visionaries from the healthcare industry and the investment community to discuss and debate the trends set to reshape the industry far into the future.
Wednesday, 7th to Sunday, 10th November
8 a.m. – 7 p.m. EST
Meet with ImaginAb’s Ian Wilson, CEO, Ivan Plavec, CBO, and Anna Wu, Ph.D., Scientic Advisor, during the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting, at the Gaylord National Hotel & Convention Center in National Harbor, MD. Team ImaginAb will be in Booth #646 from November 7 – 10, 2019 during the conference.
The SITC Annual Meeting & Pre-Conference Programs is the leading destination for scientific exchange, education and networking in the cancer immunotherapy field.